Compared to mycophenolate mofetil (MMF) regimen what was the result of everolimus regimen on Composite efficacy failure event rates at month 12?
The eGFR levels were higher for the everolimus group through the study but the treatment comparisons did not show any statistically significant differences between the groups at any time point (Table 4; see also Additional file 2).